Arpita Desai, Medical Director of GU Medical Oncology, Associate Professor at UC San Francisco, shared a post on X:
“What an absolute honor to chair the papillary RCC Education Session at ASCO26!
Papillary renal cell carcinoma is a disease that demands our attention, and this session covered the full spectrum – biology frontline refractory disease.
I was thrilled to review subsequent lines + novel therapeutic approaches for refractory papillary RCC , including the emerging strategies and clinical trial opportunities that give me so much hope for our patients.
Huge thanks to my incredible co-faculty Dr. Ramaprasad Srinivasan and Charles Nguyen for such an engaging discussion – collaboration like this is what moves the field forward!”
Other articles featuring Arpita Desai on OncoDaily.